Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer — Stella

Home/Biliary Tract Cancer/A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

View on ClinicalTrials.gov

Recruiting

Back to Biliary Tract Cancer trials

A Study of SHR-A1904 in Previous Systemic Treatment Failed Biliary Tract Cancer

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

China

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, Beijing Municipality

Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality

Key details

Phase

Safety & dosing

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Enrollment target

~151 participants

Started

March 2026

Primary completion

December 2030

Age range

18 Years – 75 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.